BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9076628)

  • 1. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C.
    Kobayashi M; Tanaka E; Matsumoto A; Ichijo T; Kiyosawa K
    J Gastroenterol Hepatol; 1997 Jan; 12(1):73-6. PubMed ID: 9076628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis.
    Tanaka E; Kiyosawa K; Shimoda K; Hino K; Tacke M; Schmolke S; Engel AM; Hess G
    J Viral Hepat; 1998 May; 5(3):153-9. PubMed ID: 9658367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
    Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
    Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of polypeptide antigen of HCVE2/NS1 relative conservation region in detection of anti-HCV].
    Li Q; Hu X; Min F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):61-3. PubMed ID: 12759957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Multicentre Hemodialysis Cohort Study on Viral Hepatitis.
    Psichogiou M; Katsoulidou A; Vaindirli E; Francis B; Lee SR; Hatzakis A
    Transfusion; 1997 Aug; 37(8):858-62. PubMed ID: 9280333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to hepatitis C virus and elevated transaminase levels in a town of hyperendemicity in Iwate, Japan.
    Koyama T; Tsuda F; Ishikawa K; Oishi H; Tazawa M; Yoshizawa H; Sato S; Okamoto H
    J Gastroenterol Hepatol; 1997 Jan; 12(1):67-72. PubMed ID: 9076627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.
    Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D
    Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
    Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
    Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.
    Guobuzaite A; Chokshi S; Balciūniene L; Voinic A; Stikleryte A; Zagminas K; Ambrozaitis A; Naoumov N
    Medicina (Kaunas); 2008; 44(7):510-20. PubMed ID: 18695347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
    PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
    Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of anti-E2 in the diagnosis of HCV infection in patients on maintenance hemodialysis: anti-E2 is frequently detected among anti-HCV antibody-negative patients.
    Lee DS; Lesniewski RR; Sung YC; Min WK; Park SG; Lee KH; Kim HS
    J Am Soc Nephrol; 1996 Nov; 7(11):2409-13. PubMed ID: 8959633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection-associated markers in sera from blood donors in Surabaya, Indonesia.
    Darmadi S; Soetjipto ; Handajani R; Lusida MI; Soemarto ; Sakugawa H; Ishido S; Hotta H
    Microbiol Immunol; 1996; 40(5):401-5. PubMed ID: 8805106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepatitis C virus sequences in posttransfusion non-A, non-B hepatitis.
    Shibata M; Morishima T; Kudo T; Maki T; Maki S; Nagai Y
    Blood; 1991 Mar; 77(6):1157-60. PubMed ID: 1705830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2 and NS5: new antigens for detection of hepatitis C virus antibodies.
    Zaaijer HL; Vallari DS; Cunningham M; Lesniewski R; Reesink HW; van der Poel CL; Lelie PN
    J Med Virol; 1994 Dec; 44(4):395-7. PubMed ID: 7534821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.